Purpose Our purpose was to study changes in macular cone photoreceptors in Vogt-Koyanagi-Harada (VKH) disease patients after high-dose corticosteroid treatment using an adaptive optics (AO) fundus camera. Methods We retrospectively analyzed 16 eyes of eight patients with new-onset acute VKH disease that were studied retrospectively. After serous retinal detachment (SRD) had resolved, AO images were obtained using the rtx1™ AO fundus camera over a 12-month course. Cone counting was performed in the nasal, temporal, superior and inferior areas of the macula 0.75 mm from the foveal center. A control group of 30 eyes of 30 healthy subjects was established for comparison. Results In the eyes with VKH disease, the mean cone densities 0.75 mm from the foveal center were 11,847 at baseline (resolution of SRD), and 15,218, 16,684 and 17,686 cones/mm 2 , at 3, 6, and 12 months later, respectively. The mean cone densities at 3, 6, and 12 months were significantly increased compared to those of baseline (p = 0.007, p < 0.001, and p < 0.001, respectively); however, they were significantly lower than that of the healthy control eyes (p < 0.001). The mean cone densities at areas with a previous presence of cystoid spaces were significantly lower than those without cystoid spaces at the baseline, and at 3, 6, and 12 months (p < 0.001, p = 0.007, p < 0.001, and p = 0.008, respectively). Conclusions Cone densities were gradually increased after the resolution of SRD in the eyes of VKH disease patients. The presence of cystoid spaces might be a marker of severe damage to cone photoreceptors.
Introduction
Vogt-Koyanagi-Harada (VKH) disease is characterized by bilateral and diffuse choroiditis that usually manifests as serous retinal detachment in the acute stage, with the onset of granulomatous anterior segment inflammation soon thereafter [1] . There are well-known prodromal symptoms involving the central nervous system and the auditory system that aid in the diagnosis of VKH disease at this acute stage. If the disease is left untreated, or is undertreated, the ocular inflammation becomes chronic, with an increased risk of various ocular complications, as well as an increased risk of late integumentary changes such as poliosis, vitiligo, and alopecia [2] . Patients with VKH disease are usually treated with high-dose systemic corticosteroids, either only orally or with an initial intravenous administration followed by oral administration.
Several studies have used optical coherence tomography (OCT) to reveal the structural changes in the retina that occur in VKH disease [3] . However, the effects of inflammation and subretinal exudation on cone photoreceptors in the macula of VKH disease remain unexplored. Our group and other researchers have used adaptive optics (AO) imaging clinically to directly visualize cone photoreceptors [4, 5] . Our analyses revealed that the macular cone density values in patients with resolved central serous chorioretinopathy were lower than those in normal eyes, but the values increased gradually in the 12 months [5] . Like central serous chorioretinopathy, VKH disease involves serous retinal detachment (SRD) of the macula; we thus speculated that the macular cone photoreceptors in VKH eyes were damaged by SRD and recovered with time after the SRD has resolved in VKH eyes. In this study, we retrospectively investigated cone loss and changes in the cone density in patients with VKH during their followup period that were identified with an AO fundus camera, and we determined the correlations between cone loss and cone density changes with the forms of SRD.
Patients and methods
This was a single-center, retrospective study that was conducted in accordance with the Institutional Guidelines of the University of Toyama and was approved by the university's Institutional Review Board. The procedures conformed to the tenets of the World Medical Association's Declaration of Helsinki. All subjects gave their written informed consent before participation in this retrospective study.
Patients
We examined the 16 eyes of eight consecutive patients with new-onset acute VKH disease who visited Toyama University Hospital between January 2013 and July 2015. The diagnosis of VKH was based on established international criteria [2] . Only patients with SRD involving the foveal center before steroid treatment were included in this study. All patients underwent comprehensive eye examinations at the initial visit before treatment, including the measurement of decimal bestcorrected visual acuity (BCVA), a fundus examination, standard spectral domain (SD) OCT, enhanced depth imagingoptical coherence tomography (EDI-OCT) (RS-3000 Advance, Nidek, Aichi, Japan), fluorescein angiography, and indocyanine green angiography. The standard OCT and EDI-OCT were performed at the initial visit before treatment, every 2 to 3 days over the first 2 weeks, every 2 weeks until the SRD resolved, and then every month thereafter. All patients received an intravenous administration of methylprednisolone (1000 mg/day) for 3 days followed by tapering oral doses of prednisolone. One patient received oral prednisolone and cyclosporine concomitantly. To establish a healthy control group for comparison to the patients with VKH disease, we also included 30 eyes from 30 healthy volunteer subjects.
Adaptive optics imaging and the measurement of cone density
After the patient's SRD was resolved by high-dose corticosteroid treatment, AO images were obtained at the macula. AO images were taken in the nasal, temporal, superior and inferior areas at 0.75 mm from the foveal center in each eye with a rtx1™ AO fundus camera (Imagine Eyes, Orsay, France). The images were processed with software tools supplied by the manufacturer (CK V.1.3 and AOdetect V.0.1). These images were registered using a cross-correlation method and averaged to produce a final image with an enhanced signal-to-noise ratio [6] . Montage images were created using image editing software (Photoshop Elements 11; Adobe, Mountain View, CA, USA).
Cone counting was performed in the nasal, temporal, superior, and inferior areas at 0.75 mm from the foveal center (Fig. 1) . The size of the counting areas was set as 100 μm × 100 μm square. Scales of the macular images were calculated using Littmann's method [7] . Cone density was counted automatically using AOdetect software (Imagine Eyes).
We defined each patient's baseline as the first time that the resolution of the SRD was confirmed by the vertical and horizontal OCT images was set as the baseline. Measurements of cone density using AO images were performed at the baseline, and at 3, 6, and 12 months after the baseline at the same locations in each eye.
We used the mean value of the cone density of each of the four locations (the nasal, temporal, superior, and inferior areas) to compare the mean cone density of the healthy control eyes and to analyze the correlations between the choroidal thickness and the mean areas of subretinal fluid (SRF), cystoid space, and the SRF + cystoid space.
To further investigate the relationship between the presence or absence of SRF or cystoid space and the cone density, we analyzed the forms of SRD in OCT at 0.75 mm from the foveal center at each patient's initial visit before treatment, corresponding to the cone density measurement site. The cone densities of the nasal, temporal, superior, and inferior areas at 0.75 mm from the foveal center were separated into the areas with the previous presence of SRF and/or cystoid space and the areas without previous SRF or cystoid space. Changes in the mean cone densities were evaluated in these groups of areas.
Measurement of the areas of subretinal fluid and cystoid space
We used horizontal and vertical slices of OCT crossing the foveal center taken at each patient's initial visit before treatment to identify the locations of SRF and cystoid spaces and then measure the areas (Fig. 2) . As reported, serous retinal detachment in VKH disease shows both intra-retinal fluid (cystoid space) and SRF [3] . Each area was manually measured using ImageJ software (U.S. National Institutes of Health, Bethesda, MD).
Measurement of the subfoveal choroidal thickeness
The subfoveal choroidal thickness was measured using EDI-OCT images. Choroidal thickness was determined between the outer border of the retinal pigment epithelium and the outer border of the choroid under the foveal center. The subfoveal cohoroidal thickness measurements were performed at the resolution of SRD (i.e., the baseline), and at 3, 6, and 12 months after the baseline measurement. The mean value of the vertical and horizontal thickness was used for analysis.
Statistical analysis
Statistical analyses were performed with JMP® 11 (SAS Institute, Cary, NC, USA). The decimal visual acuity was converted to the logarithm of the minimal angle of resolution (logMAR) unit for statistical analysis. The paired t-test or Mann-Whitney U-test was used, and two-tail p-values <0.05 were considered significant. We used the Spearman rank correlation and was calculated to assess the correlation among the data.
Results
The mean age of the VKH patient group (mean ± standard deviation) was 39.5 ± 12.0 years (range, 25-54 years), and that of the healthy control group was 34.5 ± 9. The compartment that had detached leaving only the retinal pigment epithelium was defined as subretinal fluid (SRF), and the fluid inside the retina was defined as a cystoid space. Areas of SRF and cystoid space were manually measured and 3, 6, and 12 months compared to that before steroid treatment (p = 0.005, p = 0.003, p = 0.001, p = 0.001, respectively). Compared to the baseline value, the mean BCVA at 6 and 12 months was significantly improved (p = 0.04, p = 0.005, respectively). When the patients' SRD had resolved (baseline), 12 of the 16 eyes had improved to −0.08 logMAR units (1.2 on decimal visual acuity) or more. Three months after the baseline, 15 of the 16 eyes had improved to −0.08 logMAR units or more and maintained that acuity until the study's end. There was no significant correlation between the mean area of SRF or cystoid space and the logMAR BCVA values at the before-treatment point, the baseline, or at 3, 6, or 12 months. The mean area of SRF + cystoid space was significantly correlated with logMAR BCVA at before-treatment (ρ = 0.84, p < 0.001). There was no significant correlation between the mean area of SRF + cystoid space and logMAR BCVA at the baseline, or at 3, 6, or 12 months.
As shown in Fig. 3 , the mean cone densities at 0.75 mm from the foveal center of all 16 VKH eyes at baseline and at 3, 6, and 12 months were 11,847 ± 6243, 15,218 ± 6839, 16,684 ± 5033, and 17,686 ± 4183 cones/mm 2 , respectively. The mean cone densities at 3, 6, and 12 months were significantly increased compared to those at baseline (p = 0.007, p < 0.001, and p < 0.001, respectively). In the healthy eyes, the mean cone density at 0.75 mm from the foveal center was 24,496 ± 3220 cones/mm 2 . Throughout the 12-month observation period, the mean cone densities measured in the eyes of the patients with VKH were significantly lower than those in the healthy control eyes (p < 0.001) (Fig. 4) .
The correlations between the mean cone densities and the mean area of SRF, cystoid space, and SRF + cystoid space in each eye are shown in Fig. 5 and Table 1 . The mean SRF area was not correlated with the mean cone densities until 12 months after baseline. However, the mean area of the cystoid space was significantly correlated with the mean cone density at the baseline (ρ = −0.64; p = 0.004). The area of SRF + cystoid space was associated with the mean cone densities at baseline and at 3 and 6 months (ρ = −0.62, p = 0.005; ρ = −0.57, p = 0.01; and ρ = −0.47, p = 0.04, respectively).
We also examined the changes in cone densities that were also examined in relation to the previous presence or absence of SRF and/or cystoid space. The previous presence or absence of SRF did not significantly affect the recovery of the mean cone density at any observation point (Fig. 6a) . However, the mean cone densities with the previous presence of cystoid space were significantly lower than those without cystoid space at baseline, 3, 6, and 12 months (p < 0.001, p = 0.007, p < 0.001, and p = 0.008, respectively) (Fig. 6b) . Typical changes of cone density are shown in Fig. 7 .
The mean choroidal thicknesses as measured by EDI-OCT of all 16 VKH eyes at baseline (i.e., the resolution of SRD) and at 3, 6, and 12 months after the baseline were 335 ± 89 μm, 333 ± 83 μm, 313 ± 79 μm, and 303 ± 82 μm, respectively. The mean choroidal thickness was significantly decreased at 6 and 12 months compared to the baseline (p = 0.01 and p = 0.01, respectively). There were no significant correlations between the mean choroidal thickness at baseline and the mean areas of SRF, cystoid space, and SRF + cystoid space (ρ = −0.16, p = 0.53; ρ = 0.35, p = 0.17; and ρ = 0.23, p = 0.38, respectively). The correlations between the mean cone density and the mean subretinal choroidal thickness at baseline and at 3, 6 and 12 months after the Fig. 4 Box plots of the mean cone densities (the mean value of cone densities of the nasal, temporal, superior, and inferior areas from the foveal center) at 12 months in eyes with Vogt-Koyanagi-Harada disease and in healthy control eyes. Centerlines show the medians; box limits indicate the 25th and 75th percentiles; whiskers extend to 1.5 times the interquartile range from the 25th and 75th percentiles; outliers are represented by dots. n = 16, 30 sample points Table 2 . There were significant correlations between the mean cone density and the mean subretinal choroidal thickness at 3 months and 6 months after baseline (ρ = −0.51, p = 0.02; and ρ = −0.50, p = 0.04, respectively).
Discussion
We observed cone densities in the eyes of patients with VKH disease for a 12-month period after the resolution of their serous retinal detachment (SRD). The mean cone density gradually increased throughout the follow-up period. According to previous studies, the cone mosaic corresponds to the outer segments (OS) of the photoreceptors [8] [9] [10] . Zhang et al., studied the correlation between AO images and SD-OCT images by using a high-speed adaptive optics SD-OCT camera and found that the regular distribution of bright spots observed within the C-scans at the inner segment/ outer segment junctions (referred to as the ellipsoid zone) and those at the posterior tips of the OS were highly correlated with one another, as well as with the expected cone spacing [8] . The results of our present study's AO imaging provided direct evidence indicating that the OS was damaged in the eyes of VKH patients.
It has been demonstrated that there are two main causes of OS damage in eyes with VKH. The first cause of the OS damage is damage due to inflammation. Yamaki et al., observed shortening and degenerative changes of the OS in a tyrosinase-protein-1-and −2-induced experimental autoimmune uveitis rat model [9] . In another animal model of VKH, Hayakawa et al., reported that the photoreceptor OS, outer nuclear layer, and outer plexiform layer were partly destroyed when the severe inflammation extended into the retinal layer [10] . These animal models of VKH strongly suggest that inflammation induces OS damage. The second cause of the OS damage is damage due to SRD. In an experimental retinal detachment model, Sakai et al., reported that the OS length measurements of short and middle-wavelengthsensitive cones demonstrated the shortening of the OS by retinal detachment [11] . We and others have used AO imaging in a clinical setting to visualize the cone densities of eyes with central serous chorioretinopathy or rhegmatogenous retinal detachment [4, 5, 12] .
Bae et al., evaluated the photoreceptor outer segment (PROS) volume in VKH patients using spectral domain OCT, and they reported that the PROS volume decreased after the total resolution of macular SRF; however, the PROS volume increased at the final follow-up visit [17] . They hypothesized that the PROS shortening occurred in response to inflammation, and that once the inflammatory stimulus had been removed, the OS enlarged and recovered. Sakai et al., reported that the OS was shortened after retinal detachment, but progressively recovered after reattachment and continued for 96 days after reattachment [11] .
In contrast to these OCT studies, our results showed that the mean cone density in the VKH eyes did not recover to the healthy control levels, even at 12 months after the resolution of serous retinal detachment. This indicates that compared to Table 1 Correlation between the mean cone density (the mean value of cone densities of four locations; nasal, temporal, superior and inferior from the foveal center) and the mean area of subretinal fluid, cystoid space, and SRF + cystoid space We also observed that the mean area of cystoid space was correlated with the mean cone density at baseline and that the mean cone densities at areas with cystoid space were significantly lower than those of areas without cystoid space. In the acute phase of VKH disease, SRD involving the septa occurs, forming a cystoid space. It is hypothesized that this septa and membrane structure is a part of the retinal structure and is composed of inflammatory products such as fibrin [3, 13, 14] . Ishihara et al., analyzed serous retinal detachment in VKH disease using SD-OCT and found that the membranous structure was continuous with the IS/OS junction of the attached area [15] . These results suggested that the membranous structure and cystoid spaces resulted from an extension or break of the outer limiting membrane and the formation of inflammatory products such as fibrin.
Lee et al., speculated that cystoid spaces caused the outer segments to separate from the inner segments [16] . Because SRF causes the outer segments to detach from the retinal pigment epithelium, the formation of cystoid space may cause more damage to the photoreceptors than the formation of SRF. This appears to be supported by the findings reported by Bae et al., which showed that the PROS volumes were decreased in VKH cases with a high fibrinous index after serous retinal detachment resolution [17] .
Although the mean cone density of our present VKH group at 12 months after the baseline was lower than that of the healthy control group, the visual acuity was −0.08 logMAR units or more at 12 months after the baseline in 15 of the 16 VKH eyes. Similarly, we and others reported that even though the cone density was decreased, the visual acuity was well maintained in resolved central serous retinopathy and rhegmatogenous retinal detachment eyes [5, 12] . It has been speculated that the redundancy of cone photoreceptors to retinal ganglion cells may exist to preserve the visual acuity [18] .
Patients with VKH disease showed an increase in choroidal thickness, and this was decreased by steroid treatment [19, 20] . Nakayama et al., noted that the choroidal thickness at 1 week after treatment was correlated with the occurrence of peripapillary atrophy after 12 months, and they suggested that the choroidal thickness may serve as a marker of choroidal inflammation in acute VKH disease [20] . In the present study, we observed a negative correlation between the subfoveal choroidal thickness and the mean cone density at 3 months and 6 months. Considering that the choroidal thickness is related to the choroidal inflammation in VKH disease, the recovery of the cone photoreceptors may be delayed in patients with persistent inflammation after several months of treatment.
There are some limitations to our study such as the small number of cases, the relatively short (1-year) follow-up, and the retrospective nature of the study. Moreover, current AO imaging is not able to show individual cone photoreceptors in the foveal center. However, we, for the first time, visualized longitudinal changes during the recovery of cone photoreceptors in the eyes of VKH patients. Still, even at 12 months after the resolution of serous retinal detachment, the mean cone density of the VKH eyes was lower than that of the healthy controls. Cystoid spaces in the OCT image might induce more damage to the cone photoreceptors than subretinal fluid. Further studies with longer follow-ups are needed to clarify the recovery of macular cone density in VKH disease.
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